Moderna stock soared early in the pandemic thanks to sales of its coronavirus vaccine. After soaring to success in the early ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

Interest in what caused the coronavirus pandemic has many political dimensions today, with President Trump saying genetic ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

Barclays Speaking the Science Call Series, on Monday, June 16 th at 10:00am ET A live webcast of this presentation will be available under "Events and Presentations" in the Investors section of the ...

Daniel Suárez se ha convertido en el guía turístico no oficial de todo lo relacionado con la Ciudad de México mientras NASCAR ...

The second of this two-part article explores what organizations should consider when trying to optimize a mixed team of ...

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.